{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T03:24:49Z","timestamp":1780629889253,"version":"3.54.1"},"reference-count":29,"publisher":"Archives of Pathology and Laboratory Medicine","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Context.\u2014Li-Fraumeni syndrome (LFS), characterized by predisposition to early onset of a variety of malignancies, is usually associated with germline mutation of the tumor-suppressor gene, TP53. Mutation carriers are at increased risk of multiple primary tumors, many of which arise in previous radiation-therapy sites. In patients with LFS, acute myeloid leukemia is uncommon and myelodysplastic syndrome (MDS) is rare.<\/jats:p>\n                  <jats:p>Objective.\u2014To evaluate the morphologic, cytogenetic, and molecular diagnostic findings of 3 unique cases of MDS arising in patients with germline TP53 mutation, 2 with classic LFS.<\/jats:p>\n                  <jats:p>Design.\u2014We searched the Li-Fraumeni Syndrome Registry in the Department of Genetics at the University of Texas M. D. Anderson Cancer Center (Houston, Texas) and identified 3 patients with documented germline TP53 mutations or LFS who had developed MDS during a period of 6 years (2000\u20132005). The clinical, cytogenetic, and molecular diagnostic data and bone marrow aspirate smears and biopsies on all patients were reviewed. Immunohistochemical staining with antibody to p53 was also performed.<\/jats:p>\n                  <jats:p>Results.\u2014Two patients met the criteria for classic LFS; one had no history of malignancy in first-degree relatives. The MDS followed chemotherapy and radiation therapy and progressed to acute myeloid leukemia in 2 patients. Cytogenetic analysis demonstrated chromosome 5 abnormalities in a complex karyotype in all cases. Two patients died, one of acute myeloid leukemia and one with glioblastoma multiforme, MDS, and persistent pancytopenia.<\/jats:p>\n                  <jats:p>Conclusions.\u2014Patients with LFS may develop MDS, which is most likely therapy-related and is associated with cytogenetic markers of poor prognosis.<\/jats:p>","DOI":"10.5858\/2009-0015-oa.1","type":"journal-article","created":{"date-parts":[[2021,2,12]],"date-time":"2021-02-12T12:33:26Z","timestamp":1613133206000},"page":"1010-1015","source":"Crossref","is-referenced-by-count":53,"title":["Myelodysplastic Syndromes Arising in Patients With Germline\n                    <i>TP53<\/i>\n                    Mutation and Li-Fraumeni Syndrome"],"prefix":"10.5858","volume":"134","author":[{"given":"Sameer S.","family":"Talwalkar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Cameron Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rizwan C.","family":"Naeem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"John Hicks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise C.","family":"Strong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynne V.","family":"Abruzzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3906","published-online":{"date-parts":[[2010,7,1]]},"reference":[{"issue":"4","key":"2021021103504908500_i1543-2165-134-7-1010-b01","doi-asserted-by":"crossref","first-page":"747","DOI":"10.7326\/0003-4819-71-4-747","article-title":"Soft tissue sarcomas, breast cancers and other neoplasms: a familial syndrome?","volume":"71","author":"Li","year":"1969","journal-title":"Ann Intern Med"},{"issue":"4985","key":"2021021103504908500_i1543-2165-134-7-1010-b02","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1126\/science.1978757","article-title":"Germ-line p53 mutations in a familial syndrome of breast cancer, sarcomas and other neoplasms.","volume":"250","author":"Malkin","year":"1990","journal-title":"Science"},{"key":"2021021103504908500_i1543-2165-134-7-1010-b03","article-title":"Online Mendelian Inheritance in Man."},{"issue":"8","key":"2021021103504908500_i1543-2165-134-7-1010-b04","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1200\/JCO.2008.16.6959","article-title":"Beyond Li-Fraumeni syndromes: clinical characteristics of families with p53 germline mutations.","volume":"27","author":"Gonzalez","year":"2008","journal-title":"J Clin Oncol"},{"issue":"18","key":"2021021103504908500_i1543-2165-134-7-1010-b05","first-page":"5358","article-title":"A cancer family syndrome in twenty-four kindreds.","volume":"48","author":"Li","year":"1988","journal-title":"Cancer Res"},{"issue":"9","key":"2021021103504908500_i1543-2165-134-7-1010-b06","doi-asserted-by":"crossref","first-page":"3982","DOI":"10.1128\/MCB.9.9.3982","article-title":"High incidence of lung, bone and lymphoid tumors in transgenic mice overexpressing mutant alleles of p53 oncogene.","volume":"9","author":"Lavigueur","year":"1989","journal-title":"Mol Cell Bio"},{"issue":"6303","key":"2021021103504908500_i1543-2165-134-7-1010-b07","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/348747a0","article-title":"Germ-line transmission of mutated p53 gene in cancer prone family with Li-Fraumeni syndrome.","volume":"348","author":"Srivastava","year":"1990","journal-title":"Nature"},{"issue":"8781","key":"2021021103504908500_i1543-2165-134-7-1010-b08","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1016\/0140-6736(91)92303-J","article-title":"p53 germline mutations in Li-Fraumeni syndrome.","volume":"338","author":"Santibanez-Koref","year":"1991","journal-title":"Lancet"},{"issue":"2","key":"2021021103504908500_i1543-2165-134-7-1010-b09","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1172\/JCI115630","article-title":"Hereditary and acquired p53 mutations in childhood acute lymphoblastic leukemia.","volume":"89","author":"Felix","year":"1992","journal-title":"J Clin Invest"},{"issue":"20","key":"2021021103504908500_i1543-2165-134-7-1010-b10","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJM199205143262002","article-title":"Germline mutations of the p53 tumor suppressor gene in children and young adults with second malignant neoplasms.","volume":"326","author":"Malkin","year":"1992","journal-title":"N Engl J Med"},{"key":"2021021103504908500_i1543-2165-134-7-1010-b11","article-title":"Online Mendelian Inheritance in Man."},{"issue":"15","key":"2021021103504908500_i1543-2165-134-7-1010-b12","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1038\/sj.onc.1210302","article-title":"TP53 mutations in human cancers: functional selection and impact on cancer prognosis and outcomes.","volume":"26","author":"Petitjean","year":"2007","journal-title":"Oncogene"},{"issue":"23, pt 1","key":"2021021103504908500_i1543-2165-134-7-1010-b13","first-page":"6385","article-title":"A germline mutation in exon 5 of the p53 in an extended cancer family.","volume":"51","author":"Law","year":"1991","journal-title":"Cancer Res"},{"issue":"10","key":"2021021103504908500_i1543-2165-134-7-1010-b14","doi-asserted-by":"crossref","first-page":"4376","DOI":"10.1182\/blood.V87.10.4376.bloodjournal87104376","article-title":"The p53 gene in pediatric therapy-related leukemia and myelodysplasia.","volume":"87","author":"Felix","year":"1996","journal-title":"Blood"},{"issue":"5","key":"2021021103504908500_i1543-2165-134-7-1010-b15","doi-asserted-by":"crossref","first-page":"490","DOI":"10.2169\/internalmedicine.44.490","article-title":"A patient with TP53 germline mutation developed Bowen's disease and myelodysplastic syndrome with myelofibrosis after chemotherapy against ovarian cancer.","volume":"44","author":"Kuribayashi","year":"2005","journal-title":"Intern Med"},{"issue":"4","key":"2021021103504908500_i1543-2165-134-7-1010-b16","first-page":"734","article-title":"Acute myelogenous leukemia in a patient with Li-Fraumeni syndrome treated with valproic acid, theophyllamine and all-trans retinoic: a case report. Leukemia.","volume":"20","author":"Anensen","year":"2006"},{"key":"2021021103504908500_i1543-2165-134-7-1010-b17","first-page":"89","article-title":"Acute myeloid leukaemias and myelodysplastic syndromes, therapy related.","author":"Brunning","year":"2001","journal-title":"Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues"},{"issue":"11","key":"2021021103504908500_i1543-2165-134-7-1010-b18","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1038\/modpathol.3880448","article-title":"Leukemic Mantle cell lymphoma: clinical and pathologic spectrum of twenty-three cases.","volume":"14","author":"Schlette","year":"2001","journal-title":"Mod Pathol"},{"key":"2021021103504908500_i1543-2165-134-7-1010-b19","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1086\/374567","article-title":"Germline p53 mutations in a cohort with childhood sarcoma: sex differences in cancer risk.","volume":"72","author":"Hwang","year":"2003(4)","journal-title":"Am J Hum Genet"},{"issue":"7","key":"2021021103504908500_i1543-2165-134-7-1010-b20","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1128\/MCB.5.7.1601","article-title":"Molecular cloning and in-vitro expression of a c-DNA clone for human cellular tumor antigen p53.","volume":"5","author":"Harlow","year":"1985","journal-title":"Mol Cell Biol"},{"issue":"6","key":"2021021103504908500_i1543-2165-134-7-1010-b21","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/humu.20495","article-title":"Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database.","volume":"28","author":"Petitjean","year":"2007","journal-title":"Hum Mutat"},{"issue":"1","key":"2021021103504908500_i1543-2165-134-7-1010-b22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/path.1913","article-title":"Assessing p53 in clinical contexts: unlearned lessons and new perspectives.","volume":"208","author":"Hall","year":"2006","journal-title":"J Pathol"},{"issue":"6","key":"2021021103504908500_i1543-2165-134-7-1010-b23","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1182\/blood.V89.6.2079","article-title":"International scoring system for evaluating prognosis in myelodysplastic syndromes.","volume":"89","author":"Greenberg","year":"1997","journal-title":"Blood"},{"issue":"9","key":"2021021103504908500_i1543-2165-134-7-1010-b24","doi-asserted-by":"crossref","first-page":"3148","DOI":"10.1182\/blood.V84.9.3148.3148","article-title":"p53 mutations are associated with resistance to chemotherapy and short survival in hematologic malignancies.","volume":"84","author":"Wattel","year":"1994","journal-title":"Blood"},{"issue":"2","key":"2021021103504908500_i1543-2165-134-7-1010-b25","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1046\/j.1365-2141.2001.03073.x","article-title":"International prognostic scoring system and TP53 mutations are independent prognostic indicators for patients with myelodysplastic syndrome.","volume":"115","author":"Kita-Sasai","year":"2001","journal-title":"Br J Haematol"},{"issue":"6","key":"2021021103504908500_i1543-2165-134-7-1010-b26","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1080\/1042819031000067620","article-title":"Configuration of the TP53 gene as an independent prognostic parameter of myelodysplastic syndrome.","volume":"44","author":"Horiike","year":"2003","journal-title":"Leuk Lymphoma"},{"issue":"11","key":"2021021103504908500_i1543-2165-134-7-1010-b27","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.1182\/blood.V81.11.3022.3022","article-title":"Mutations of the p53 gene in myelodysplastic syndrome (MDS) and MDS-derived leukemia.","volume":"81","author":"Sugimoto","year":"1993","journal-title":"Blood"},{"issue":"2","key":"2021021103504908500_i1543-2165-134-7-1010-b28","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/sj.leu.2405078","article-title":"Genetics of therapy-related myelodysplasia and acute myeloid leukemia.","volume":"22","author":"Pedersen-Bjergaard","year":"2008","journal-title":"Leukemia"},{"issue":"8","key":"2021021103504908500_i1543-2165-134-7-1010-b29","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1093\/jnci\/90.8.606","article-title":"Multiple primary cancers in families with Li-Fraumeni syndrome.","volume":"90","author":"Hisada","year":"1998","journal-title":"J Natl Cancer Inst"}],"container-title":["Archives of Pathology &amp; Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/meridian.allenpress.com\/aplm\/article-pdf\/134\/7\/1010\/2769795\/2009-0015-oa_1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/meridian.allenpress.com\/aplm\/article-pdf\/134\/7\/1010\/2769795\/2009-0015-oa_1.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T19:38:30Z","timestamp":1764790710000},"score":1,"resource":{"primary":{"URL":"https:\/\/aplm.kglmeridian.com\/view\/journals\/arpa\/134\/7\/article-p1010.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7,1]]},"references-count":29,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2010,7,1]]},"published-print":{"date-parts":[[2010,7,1]]}},"URL":"https:\/\/doi.org\/10.5858\/2009-0015-oa.1","relation":{},"ISSN":["1543-2165","0003-9985"],"issn-type":[{"value":"1543-2165","type":"electronic"},{"value":"0003-9985","type":"print"}],"subject":[],"published":{"date-parts":[[2010,7,1]]}}}